This course will present biological models of addictive disorders and evidenced-based treatments of addictions. Topics will incorporate new research on the biological basis for genomic subtypes of addiction. Emphasis will be on the translation of basic science to the clinic, strategies for pharmacotherapy, incorporating a biologic framework of addiction into addiction psychoeducation and programming, and individualized approaches to the treatment of addictions with comorbid psychiatric diagnoses. Outcomes based research using clinical electronic databases to enhance follow-up will also be discussed as well as the bioethics guiding the assessment and treatment of addiction as an illness.
Want to learn about the latest findings in genomics and how to apply them to your practice? Network with professionals in your field? Share your clinical case studies and research?
Do this and more by attending the second annual IM conference, sponsored by the Mayo Clinic Center for Individualized Medicine. As new discoveries in individualized medicine make their way into practice, they present new challenges.
This conference addresses practical issues of integrating pharmacogenomics, microbiomics, epigenomics, and genomic medicine into patient care. Conference topics include the integration of drug-gene pair alerts into the EMR; understanding which patients might benefit from whole genome/exome sequencing interpretation and its relevance to prognosis and diagnosis; sharing complicated genomic information with patients; and discussion of regulatory, legal, and bioethical issues.
A pre-conference course, Omics 101, explores principles and applications of genomics and pharmacogenomics in clinical and laboratory practice.
Learn more, see speakers and detailed schedule at http://individualizingmedicineconference.mayo.edu
This course offers a broad array of lecture topics beginning with a review of basic genomics and progressing to clinical applications. It is designed for individuals with an interest in understanding the ways in which genes not only affect mental illness, but impact disease course and prognosis. Pharmacogenomic principles that guide the treatment of psychiatric illness will be specifically highlighted.